16.09.2011 • News

Bayer To Realign Diagnostics Business

Bayer is planning a restructuring of its diagnostics business, according to a report in the Financial Times Deutschland. The German pharmaceutical giant has been reportedly looking for a buyer for the Medical Imaging division, while the X-Ray contrast agents business may be merged into the Medical Care division.

The sale of the Medical Imaging division is expected to affect 100 employees who, as per the report, have already been notified of an impending sale. The diagnostics business was acquired in 2006 as part of Schering.

Special Issue

Explore the Future of Plastics

Circular Plastics Economy

This special CHEManager issue explores the industry’s pivotal shift towards a more sustainable, circular plastics value chain. Readers will find expert analysis and real-world solutions for today’s most pressing recycling and regulatory challenges.

Innovation Pitch

Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.